DIANE SCHWARZ: Open Payments
NPI 1548558554 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 30 payments from 13 companies in 2025. Trend: 2023 $1,024 · 2024 $931 · 2025 $637
Food & beverage: $562Consulting: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $183 |
| UCB, Inc. | 4 | $103 |
| Cardinal Health 110 LLC | 1 | $75 |
| Organon LLC | 3 | $50 |
| Amgen Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| SOBI, INC | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| GENZYME CORPORATION | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: SKYRIZI, RINVOQ, Bimzelx, HADLIMA, COSENTYX, Cimzia, Gamifant, TALTZ.
Industry payments across CA — which companies pay providers there.
